PMV Pharmaceuticals Inc. (PMVP)
1.40
0.05 (3.70%)
At close: Jan 15, 2025, 1:15 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 37.71M | 108.30M | 172.47M | 361.42M | 73.28M | 30.31M |
| Short-Term Investments | 165.35M | 132.76M | 124.70M | n/a | 28.21M | 31.60M |
| Long-Term Investments | 25.50M | 2.50M | 16.91M | n/a | n/a | n/a |
| Other Long-Term Assets | 190.00K | 313.00K | 221.00K | 201.00K | 201.00K | 201.00K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 4.35M | 5.95M | 4.12M | 6.68M | 607.00K | 332.00K |
| Total Current Assets | 207.41M | 247.01M | 301.29M | 364.76M | 102.09M | 62.24M |
| Property-Plant & Equipment | 19.05M | 20.49M | 13.15M | 569.00K | 739.00K | 1.02M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 44.74M | 23.30M | 30.28M | 770.00K | 940.00K | 1.22M |
| Total Assets | 252.15M | 270.31M | 331.57M | 365.53M | 103.03M | 63.46M |
| Account Payables | 3.24M | 3.00M | 3.19M | 1.61M | 2.84M | 1.04M |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 852.00K | 1.06M | 806.00K | n/a | n/a | n/a |
| Other Current Liabilities | 9.94M | 6.78M | 8.22M | 4.80M | 1.69M | 1.29M |
| Total Current Liabilities | 14.03M | 10.83M | 12.22M | 6.41M | 4.52M | 2.33M |
| Long-Term Debt | 12.43M | 13.45M | 10.79M | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 168.98M | 107.27M |
| Total Long-Term Liabilities | 12.43M | 13.45M | 10.79M | n/a | 168.98M | 107.27M |
| Total Liabilities | 26.46M | 24.28M | 23.01M | 6.41M | 173.51M | 109.60M |
| Total Debt | 13.29M | 13.98M | 11.19M | n/a | 168.93M | 107.23M |
| Common Stock | n/a | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -310.00M | -241.04M | -167.73M | -109.88M | -75.44M | -50.09M |
| Comprehensive Income | 224.00K | -445.00K | -78.00K | n/a | -3.00K | -13.00K |
| Shareholders Equity | 225.69M | 246.03M | 308.56M | 359.12M | -70.47M | -46.14M |
| Total Investments | 190.86M | 135.25M | 141.61M | n/a | 28.21M | 31.60M |